
ASND, GDS, ADSK and CDZI among after hours movers
16.46BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
DK0060615755
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
19.76
PEG Ratio
-
Book Value
24.57
Dividend Share
-
Dividend Yield
-
Earnings Share
13.05
Wall Street Target Price
305.73
EPS Estimate Current Year
10.08
EPS Estimate Next Year
8.90
EPS Estimate Current Quarter
0.7667
EPS Estimate Next Quarter
1.3167
Most Recent Quarter
-
Revenue TTM
1,047,020,032
Gross Profit TTM
955,894,976
EBITDA
263,454,000
Profit Margin
70.85%
Return On Assets TTM
9.58%
Return On Equity TTM
118.78%
Revenue Per Share TTM
16.889
Qtly Revenue Growth YOY
114.70%
Diluted Eps TTM
13.05
Qtly Earnings Growth YOY
0.00%
Trailing PE
19.76
Forward PE
21
Price Sales TTM
16.2105
Price Book MRQ
10.2722
Enterprise Value Revenue
13
Enterprise Value EBITDA
75
256.90
6.51%408.80
5.24%935.99
4.18%546.21
0.75%160.87
0.74%900.30
0.00%139.16
0.00%34.78
-0.91%900.00
-0.41%321.00
-0.03%